Actuate Therapeutics, Inc. · NASDAQ:ACTU

Actuate Therapeutics, Inc. insider trades

Actuate Therapeutics, Inc.'s insiders made 1 buy and 0 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Oct 28, 2026Schmitt Daniel MBuy140,844US$0.36Form 4

Actuate Therapeutics, Inc. shareholders